The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
cyclopropyl(4-((1-isobutyl-1H-benzo[d]imidazol-2-yl)methyl)piperazin-1-yl)methanone ID: ALA4869532
PubChem CID: 164621925
Max Phase: Preclinical
Molecular Formula: C20H28N4O
Molecular Weight: 340.47
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)Cn1c(CN2CCN(C(=O)C3CC3)CC2)nc2ccccc21
Standard InChI: InChI=1S/C20H28N4O/c1-15(2)13-24-18-6-4-3-5-17(18)21-19(24)14-22-9-11-23(12-10-22)20(25)16-7-8-16/h3-6,15-16H,7-14H2,1-2H3
Standard InChI Key: ZHQFLHNJTHLSTG-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
25.2354 -26.8450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2342 -27.6724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9490 -28.0853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9472 -26.4323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6625 -26.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6674 -27.6678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4549 -27.9187 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.9368 -27.2471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4470 -26.5815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.6974 -25.7954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1417 -25.1856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7617 -27.2423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1700 -26.5254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.9992 -26.5271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4075 -25.8143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9943 -25.0999 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.1683 -25.1028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.7556 -25.8201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4052 -24.3845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2302 -24.3828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9912 -23.6710 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.9438 -24.7926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9421 -23.9676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3921 -24.3995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3358 -25.3619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
9 10 1 0
10 11 1 0
8 12 1 0
12 13 1 0
13 14 1 0
13 18 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
16 19 1 0
19 20 1 0
19 21 2 0
22 20 1 0
23 22 1 0
20 23 1 0
11 24 1 0
11 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 340.47Molecular Weight (Monoisotopic): 340.2263AlogP: 2.75#Rotatable Bonds: 5Polar Surface Area: 41.37Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.32CX LogP: 2.60CX LogD: 2.59Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.84Np Likeness Score: -1.96
References 1. Ma Z, Jiang L, Li B, Liang D, Feng Y, Liu L, Jiang C.. (2021) Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity., 46 [PMID:34403955 ] [10.1016/j.bmc.2021.116352 ]